---
title: "Insights into Beyond Air Q3 Earnings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275903647.md"
description: "Beyond Air (NASDAQ:XAIR) reported Q3 earnings on February 13, 2026, missing estimates by 14.86% with an EPS of $-0.85 compared to the expected $-0.74. Revenue increased by $1.12 million year-over-year. In the previous quarter, the company also missed EPS estimates, resulting in a 16.09% drop in share price. Past performance shows a consistent trend of missing EPS estimates while revenue has varied."
datetime: "2026-02-13T12:42:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275903647.md)
  - [en](https://longbridge.com/en/news/275903647.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275903647.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275903647.md) | [繁體中文](https://longbridge.com/zh-HK/news/275903647.md)


# Insights into Beyond Air Q3 Earnings

The Q3 earnings report for **Beyond Air** (NASDAQ:XAIR) was released on Friday, February 13, 2026 at 07:30 AM.

Here's what investors need to know about the latest announcement.

### Earnings

Beyond Air missed estimated earnings by -14.86%, reporting an EPS of $-0.85 versus an estimate of $-0.74.

Revenue was up $1.12 million from the same period last year.

### Past Earnings Performance

Last quarter the company missed on EPS by $0.65 which was followed by a 16.09% drop in the share price the next day.

Here's a look at Beyond Air's past performance:

**Quarter**

**Q2 2026**

**Q1 2026**

**Q4 2025**

**Q3 2025**

**EPS Estimate**

\-0.60

\-0.60

\-0.14

\-0.18

**EPS Actual**

\-1.25

\-1.53

\-1.80

\-3

**Revenue Estimate**

2.54M

1.76M

1.39M

980K

**Revenue Actual**

1.82M

1.76M

1.15M

1.07M

To track all earnings releases for Beyond Air visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [Beyond Air, Inc. (XAIR.US)](https://longbridge.com/en/quote/XAIR.US.md)

## Related News & Research

- [Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.](https://longbridge.com/en/news/278546987.md)
- [Analyst Warns: Failure of NeuroNOS Acquisition Could Pressure Beyond Air’s Strategy, Finances, and Stock Price](https://longbridge.com/en/news/275996491.md)
- [Air T Director Resigns as Audit Chair, Leadership Shifts](https://longbridge.com/en/news/278656474.md)
- [Air T Expands Global Footprint With Arena Aviation Acquisition](https://longbridge.com/en/news/278404252.md)
- [Is Delta Air Lines Stock Underperforming the Nasdaq?](https://longbridge.com/en/news/278727105.md)